NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
3.880
+0.030 (0.78%)
At close: Apr 28, 2026, 4:00 PM EDT
3.927
+0.047 (1.21%)
After-hours: Apr 28, 2026, 4:10 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $314.01 million as of April 28, 2026. Its market cap has increased by 120.66% in one year.
Market Cap
314.01M
Enterprise Value
297.92M
1-Year Change
120.66%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $314.01M, an increase of 738.94%. That is a compound annual growth rate of 35.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 341.08M |
| Bicycle Therapeutics | 337.38M |
| Greenwich LifeSciences | 335.42M |
| Nautilus Biotechnology | 331.60M |
| Cabaletta Bio | 328.40M |
| Surrozen | 323.24M |
| Rezolute | 322.00M |
| Inhibikase Therapeutics | 320.45M |